Description
A hygoglycemic agent; induces insulin and somatostatin release from perfused rat pancreas from 0.03-3 μM; increases intracellular calcium levels in isolated rat pancreatic β cells at 3 μM; reduces blood glucose levels by 20% in fasted mice at 1.6 mg/kg orally; decreases blood glucose levels in an oral glucose tolerance test in normal rats, genetically diabetic KK mice, and an STZ-induced rat models of diabetess,
Formal name: N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-D-phenylalanine
Synonyms: A-4166|SDZ-DJN 608
Molecular weight: 317.4
CAS: 105816-04-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Ion Channel Modulation||Research Area|Endocrinology & Metabolism|Hormones & Receptors||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes